Jul. 1 at 8:43 AM
$PLTR !’ARK reduced its holdings in 10X Genomics Inc (NASDAQ: TXG), selling 263,618 shares from the ARKK fund for
$9,793,408. This sale continues a pattern seen earlier in the week, with the sale of 127,305 shares on Monday.
Other notable transactions include the purchase of 16,081 shares of Coinbase Global (NASDAQ: COIN) and 69,814 shares of X-Energy Inc (XE), along with the sale of 789,05 shares of Absci Corp (ABSI) and 20,797 shares of Veracyte Inc (NASDAQ: VCYT).
These transactions reflect ARK’s ongoing strategy to adjust its portfolio in response to market conditions and emerging opportunities, while maintaining a dynamic approach to investment management.
Soon 👇